Cape Town has taken a significant step in public health with the launch of the new phase of the Genomic Surveillance Project, a collaboration aimed at enhancing pathogen monitoring and analysis.

The head of health economics at the health ­department, Dr Anban Pillay, said: “Pharmaceutical companies are for profit. There are very few suppliers in the country; they know each ­other, so it was ...

South Africa is enhancing its role in global pandemic preparedness through a new phase of its genomic surveillance project, in collaboration with Germany and the EU, aimed at improving responses to ...

South Africa’s Deputy Director-General of Health, Dr Anban Pillay, says although the 100-day mission to develop vaccines or treatments after a pandemic outbreak is ambitious, it is also essential.